Early Detection of HCV in Injection Drug Users

Recruiting Observational Study
Hepatitis C Virus Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
Institute of Health Information and Statistics of the Czech Republic · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in the Czech Republic. The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Hepatitis C and setting up and testing new methods and implementation into the system of…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * age 18+ * an active injecting drug user or have used injecting drugs at any time in the past Exclusion Criteria: * not agreeing to participate in the project
Contacts

Nikola Stourac

+42073901254

nikola.stourac@uzis.cz

CONTACT

Lucie Mandelova, PhD

+420 770190 828

lucie.mandelova@uzis.cz

CONTACT